| Inhibition of Cdc42 - BioAssay Summary Rac1 protein is implicated in several events of atherosclerotic plaque development and represents a new potential pharmacological target for cardiovascular diseases. In this paper we describe a pharmacophore virtual screening followed by molecular docking calculations leading to the identification of five new Rac1 inhibitors. These compounds were shown to be more effective than the reference compound NSC23766 in reducing the intracellular levels of Rac1-GTP, thus supporting this approach for the development of new Rac1 inhibitors. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
BioActive Compounds: 4 Description: Title: Virtual screening approach for the identification of new Rac1 inhibitors. Abstract: Rac1 protein is implicated in several events of atherosclerotic plaque development and represents a new potential pharmacological target for cardiovascular diseases. In this paper we describe a pharmacophore virtual screening followed by molecular docking calculations leading to the identification of five new Rac1 inhibitors. These compounds were shown to be more effective than the reference compound NSC23766 in reducing the intracellular levels of Rac1-GTP, thus supporting this approach for the development of new Rac1 inhibitors. (PMID: 19527032) Comment Putative Target: ChEMBL Target ID: 101439 Target Type: SINGLE PROTEIN Pref Name: Cell division control protein 42 homolog Description: Cell division control protein 42 homolog Organism: Homo sapiens Tax ID: 9606 Confidence: Homologous single protein target assigned Relationship Type: Homologous protein target assigned ChEMBL target type: Target is a single protein chain Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: Scientific Literature Result Definitions
Data Table (Concise)
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||